Form 13-F position report

GILEAD SCIENCES INC

Reported by ATWOOD & PALMER INC

GILD CUSIP 375558103 Manager CIK 0001044929

Reported 351,309 shares, up 1,069 (0.3%) from the prior quarter.

Reported value 18.3%; share count 0.3% vs. the prior quarter.

Added
% of reported 13F value 2.69% This manager · Q3 2026
Shares 351,309 Quarter-end amount reported
Reported value $52,362,635 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 16565000
2022-03-31 13837000
2022-06-30 14657000
2022-09-30 14968000
2022-12-31 21207201
2023-03-31 20516011
2023-06-30 25953263
2023-09-30 25325541
2023-12-31 27415342
2024-03-31 25402677
2024-06-30 23735234
2024-09-30 29065665
2024-12-31 32260776
2025-03-31 38664709
2025-06-30 38148337
2025-09-30 38200692
2025-12-31 42938731
2026-03-31 48422556
2026-06-30 44249360
2026-09-30 52362635

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by ATWOOD & PALMER INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 351,309 +1,069 (0.3%) 2.69% $52,362,635 2026-10-08
Q2 2026 Added 350,240 +2,801 (0.8%) 2.36% $44,249,360 2026-07-08
Q1 2026 Reduced 347,439 -2,396 (-0.7%) 2.73% $48,422,556 2026-04-15
Q4 2025 Added 349,835 +5,685 (1.7%) 2.44% $42,938,731 2026-01-28
Q3 2025 Added 344,150 +68 (0.0%) 2.24% $38,200,692 2025-10-15
Q2 2025 Reduced 344,082 -985 (-0.3%) 2.38% $38,148,337 2025-07-08
Q1 2025 Reduced 345,067 -4,189 (-1.2%) 2.68% $38,664,709 2025-04-15
Q4 2024 Added 349,256 +2,576 (0.7%) 2.21% $32,260,776 2025-01-16
Q3 2024 Added 346,680 +736 (0.2%) 1.98% $29,065,665 2024-10-07
Q2 2024 Reduced 345,944 -850 (-0.2%) 1.8% $23,735,234 2024-07-10
Q1 2024 Added 346,794 +8,375 (2.5%) 1.93% $25,402,677 2024-04-10
Q4 2023 Added 338,419 +475 (0.1%) 2.22% $27,415,342 2024-01-12
Q3 2023 Added 337,944 +1,195 (0.4%) 2.22% $25,325,541 2023-10-20
Q2 2023 Added 336,749 +89,479 (36.2%) 2.32% $25,953,263 2023-07-18
Q1 2023 Added 247,270 +244 (0.1%) 1.93% $20,516,011 2023-04-21
Q4 2022 Added 247,026 +4,390 (1.8%) 1.92% $21,207,201 2023-01-31
Q3 2022 Added 242,636 +5,506 (2.3%) 1.48% $14,968,000 2022-10-12
Q2 2022 Added 237,130 +4,387 (1.9%) 1.43% $14,657,000 2022-07-21
Q1 2022 Added 232,743 +4,605 (2.0%) 1.19% $13,837,000 2022-04-29
Q4 2021 Added 228,138 +10,196 (4.7%) 1.39% $16,565,000 2022-01-24
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2482 managers reported GILEAD SCIENCES INC for Q3 2026.

Managers reporting GILEAD SCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 125,246,865 +3,402,757 0.27% $18,668,045,217 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 81,175,627 +83,893 0.25% $12,099,227,204 3 qtrs
STATE STREET CORPORATION Reduced 60,954,967 -261,585 0.26% $9,085,337,831 54 qtrs
FMR LLC Reduced 58,265,696 -8,605,120 0.37% $8,684,501,953 54 qtrs
Invesco Ltd Reduced 38,662,436 -1,156,715 0.45% $5,762,636,028 54 qtrs
Capital World Investors Reduced 35,929,833 -5,059,142 0.65% $5,355,872,692 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 35,685,818 +369,650 0.24% $5,318,971,173 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,190,640 +124,998 0.23% $4,485,711,723 54 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 27,664,121 -2,332,573 0.41% $4,123,338,000 54 qtrs
Capital Research Global Investors Added 23,980,766 +4,587,470 0.51% $3,574,341,919 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
October 08, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
351,034
Shared
0
None
275

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.